Serum levels of leucine amino peptidase (LAP) was studied along with bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), gamma glutamyl transpeptidase (GGT), alkaline phosphatase(ALP) and the ratio of AST/ALT and GGT/ AST in 26 healthy subjects and 82 patients with hepatobiliary malignancies of which 12 ware with hepatoceUular carcinoma, 12 with liver metastasis, 8 with obstrucUve jaundice, S with carcinoma of gall bladder, (; with carcinoma of pancreas and 7 with periampulisry carcinoma. 24 Of the 62 patients studied had jaundice and 28 were without jaundice.
INTRODUCTION
Leucine amino peptidase (LAP), a proteolytic enzyme, is capable of hydrolyzing L-leucyl peptides and is primarily involved in protein digestion in small intestinal mucosa. LAP is widely distributed in bacteria, plants and demonstrated in all human tissues with high activity in liver as well as in duodenum; small intestine, pancreas, testis and stromal cells of the uterus (1) . LAP has sensitivity and diagnostic Author for correspondence : Dr. (Ms) M.S. Ghadge B/2, Gnyanadeep C.H.S., 17 = Road, Santacruz (West) Mumbai-400 054 significance. Vadous liver function tests like bilirubin, AST, ALT, AST/ALT ra'oo, ALP(2) GGT, GGTIAST ratio and LAP(3) are reported to identify patients with liver disease. In virtually all other conditions the overlap is such as not to allow the discrimination between different disease categories. For this ~ AST/ALT ratio by DeRitis was advocated by Wroblewski as a better diagnostic criterion than numerical values of activities of individual tests. LAP can be used as a marker in testicular tumor (4).
There is a general agreement arnongst clinicians on the need for more specific biochemical aid in diagnosis and evaluation of the treab-~-,~nt of malignant disease. Studies have demonstrated a relationship ~n activity of enzymes and pathologic process of tumor growth (5-7). The present study was undertaken with a view to see if it fulfils the general agreement of dinidans on the need for more specific biochemical aid in diagnosis and evaluation of malignant disease as the activity of the enzymes is very closely related to the pathologic tumor growth and also to see if jaundice was in any way related to the elevated levels.
MATERIALS AND METHODS
25 healthy ambulant subjects and 52 cases with hepatobiliary and pancreatic malignancies-12 with hepatocellular carcinoma, 12 with liver metastasis, 6 with obstructive jaundice, 7 with periampullary carcinoma, 9 with carcinoma of gall bladder and 6 with carcinoma of pancreas -v~re included in this study, All 7 patients with pedampullary carcinoma had obstructive jaundice with bilirubin ranging from 3.9-43.0 rng% (median 14.7 mg%). Two pat~=nlswith liver metastasis had bilirubln levels of 2.6 rng% and 5.2 rng%. Five ~with cardnoma of gall bladder had elevated bilirubin levels ranging from 3.5-22.6 mg% (median 11.2 mg%). Amongst 6 patients with obstructive jaudice 4 had portal nodes whereas 2 had bile duct tumor. The bilirubln levels ranged from 17.0-25.3 mg% (median 20.8 rng%).
All cases studied belonged to the age group of 25-60 years and had histological evidence of malignancy. Age and sex distribution were similar between r and study group. All had normal renal functions and none had hemolytic disorders. Blood samples were allowed to clot at room temperature, r ,t~ii'~ged at 10000 q~ for half an hour and ~ _ ~aratscl sera analysed the same day. Haemolysed samples were excluded. Quality control sera were run during analysis to check precision and accuracy of the estimation.
LAP was determined by the optimized kinetic method using leucine p-nitroanilide as substrate according to the recommendations of the German Society of Clinical ~istry (8) . AST and ALT ~=re determined bythe optimized standard UV rnettmd (g). GGT was determined by the quantitative method of Szasz using L-gamma-glutamyl-3carboxy-4-nitroanilide as substrate (10) . ALP was estimated by optimised standard method using pnitrophenyl~ (11) .The AST/ALT (Deritis ratio) and GGTIAST ratio were calculated. Measurement of all the enzymes was carded out on a fully automated discrete random ~ Hitachi 717 autoanalyser.
Students't' test for unpaired numbers was used for statistical analysis after confirming homogeneity of variances. Cochran's correction was utilised in a group with heterogeneous variance.
RESULTS AND DISCUSSION
On comparing the mean levels of serum bilirubin AST, ALT, AST/ALT ral~o, GGT, GGT/AST ratio, LAP and ALP of normals and patients with hepatobiliary malignancies it was found that the mean levels of all the pamrnetem ~ere raised in malignancies in a highly significant (p < 0.001) ( Table 1) way. The levels of bllirubin, AST, ALT, ASTIALT, GGT, GGT/AST, LAP and ALP were elevated in obstructive jaundice, carcinoma of pancreas, and penampullan/carcinoma (p < 0.001). In hepatocellular carcinoma except GGT/ AST ratio all the other parameters ~ere elevated significantly (p < 0.001)whereas in carcinoma of gall bladder AST/ALT ratio did not show any significant increase. In metastaticliver disease total bilirubln and ALT did not show a significant increase. Table 2 gives a comparison ~ normals and jaundiced and non jaundiced patients with hepatobiliary malignancy. The levels of all the enzymes and ASTIALT and GGTIAST ratio except ALT were elevated significantly (p < 0.001) in non jaundiced groups, "The levels of the enzymes in jaundiced group when compared with non jaundiced group showed 2.4 times increase in AST and ALT,2.4 times increase in GGT,1.7 times increase in LAP and 2.0 times increase in ALP. AST/ALT and GGT/AST ratio did not show any increase on comparing the jaundiced and non jaundiced group indicating that bitirubin could be the cause of such elevated enzyme levels. Table 3 gives frequency of elevation of all the enzymes and ASTIALT and GGT/AST ratio. In jaundiced group AST was elevated in 24 of the 24 cases (100%), ALT showed a rise in 20 of the 24 cases (83.3%),GGT was elevated in 23 of the24 cases (95.8%), ALP in 24 of the 24 cases (100%) and LAP was elevated in 23 of the 24 cases (95.8%) whereas the ASTIALT and GGTIAST were elevated in 12 of the 24 ca~_c~s_ (50%) and 14 of the 24 cases (58.3%) ~especlively. In nonjaundk~IgroupAErwaselevaled in 19 of the 28 cases (67.g%), ALT in 6 of the 28 cases (21.4%),GGT in 20 of the 28 cases (71.4%), ALP in 23 of the 28 cases (82.1%) and LAP in 26 of the 28 cases (92.9%) whereas AST/ALT was elevated in 14 of the 28 cases (50%) and GGT/AST was elevated in 15 of the 28 cases (53.6%).
indicating that hepatic dysfunction with jaundice was the cause of elevated levels. LAP dseswith hepatic dysfunction i~e of jaundice and thus is a better indicator of hepatobiliary malignancy. Rutenburg et al (12) observed significantly elevated levels of urinary and serum LAP in all patients wi~ cancer of pancreas, but pa~entswith malignant lymphorna had increased urinary activity with normal or slightly elevated serum levels. An increase in serum activity of the enzyme during pregnancy and progressive fall in activity in immediate post partum period have b,~_,n reported previously (13, 14) . Hoffman et al (15) found elevated levels of LAP in benign disease with normal levels in carcinoma. Thus, one cannot correlate the enzyme levelswith neoplastic disease. Sathe et al (16) found that serum LAP can be used for detecting hepatic involvement in gastrointestinal tract cancer.
Conclusion
Rise in LAP seen in both jaundiced and non jaundiced group was due to hepatic dysfunction whereas the other erBymes showed a greater rise in jaundiced group as compared to non jaundiced group Our study reveals that this simple and reliable test of LAP determination is a better indicator of hepatobiliary malignancy as compared to the other conventional biochemical liver function tests.
